Dataset Open Access

Purification of HTT aa. 76-3060 -HAP40 aa. 1-371 for structural analysis 2019/10/21

Harding, Rachel; Hutchinson, Ashley; Seitova, Alma; Arrowsmith, Cheryl; Edwards, Aled

Project: Biophysical investigation of purified HTT protein samples

Experiment: Purification of HTT76-3060 -HAP401-371 from Sf9 

Date completed:­ 2019/10/21

Rationale: Purification of HTT76-3060 -HAP401-371 for structural analysis

Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research, in addition to generous funding from the CHDI Foundation and the Huntington Society of Canada. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files (371.2 kB)
Name Size
Purification of HTT76-3060 -HAP401-371 for structural analysis 20191021.docx
md5:4e151880d77df203ed169959264ef751
194.1 kB Download
Purification of HTT76-3060 -HAP401-371 for structural analysis 20191021.pdf
md5:f323a7f8e71f93ee93af9bb93b07e2bf
177.1 kB Download
32
24
views
downloads
All versions This version
Views 3232
Downloads 2424
Data volume 4.3 MB4.3 MB
Unique views 3131
Unique downloads 2020

Share

Cite as